News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Barbier Ann
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/09/2021 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 70,000 options to buy
@ $23.82, valued at
$1.7M
|
|
06/25/2020 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options to buy
@ $3.27, valued at
$130.8k
|
|
03/05/2020 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 150,000 options to buy
@ $7.66, valued at
$1.1M
|
|
01/28/2020 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 20,000 options to buy
@ $3.23, valued at
$64.6k
|
|
03/12/2019 |
4
| Barbier Ann (Chief Medical Officer) has filed a Form 4 on Translate Bio, Inc.
Txns:
| Granted 125,000 options to buy
@ $7.95, valued at
$993.8k
|
|
01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2018 |
3
| Barbier Ann (Chief Medical Officer) has filed a Form 3 on Translate Bio, Inc. |
04/26/2018 |
4
| Barbier Ann (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 30,000 options to buy
@ $6.43, valued at
$192.9k
|
|
04/26/2018 |
3
| Barbier Ann (Director) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC. |
|
|